Will Side Effect Reports Scare Fosamax Patients?

The end of 2008 was not kind to the osteoporosis drug Fosamax. The first blow to the medication came Wednesday evening, with the release of a letter in the New England Journal of Medicine, citing a finding by the U.S. Food and Drug Administration that 23 cases of esophageal cancer, possibly linked to the use of the drug, have been seen since Fosamax's 1995 market debut. The second came just seven hours later with the release of a study in the Journal of the American Dental Association...Full Story
Commenting on this article is closed.